{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:49:12Z","timestamp":1791830952886,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008716.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000}}],"reference-count":350,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008716.pub3","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T09:19:26Z","timestamp":1487841566000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Probiotics for people with hepatic encephalopathy"],"prefix":"10.1002","volume":"2021","author":[{"given":"Rohan","family":"Dalal","sequence":"additional","affiliation":[{"name":"Sydney Medical School; Westmead Hospital; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G","family":"McGee","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology and Diabetes; The Children's Hospital at Westmead; Westmead Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Riordan","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Unit; The Prince of Wales; Randwick Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela C","family":"Webster","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health; The University of Sydney; Sydney Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0001|cit1","first-page":"A800","article-title":"Randomized trial of probiotic yogurt in minimal hepatic encephalopathy - It helps to bug your patient","volume":"132","author":"Bajaj","year":"2007","journal-title":"Digestive Disease Week"},{"issue":"7","key":"10.1002\/14651858.CD008716.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0003|cit3","unstructured":"McGee R Request for clinical trial information [personal communication] Email to: JS Bajaj"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Bajaj JS Heuman D Hylemon P Sanyal A Sterling R Stravitz R Systems biology analysis of probiotic lactobacillus GG in cirrhotic patients with minimal hepatic encephalopathy: a randomized double-blind, placebo-controlled trial Journal of Hepatology 2014 1 S221","DOI":"10.1016\/S0168-8278(14)60618-8"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Bajaj JS Heuman DM Hylemon PB Sanyal AJ Puri P Sterling RK Randomised clinical trial: lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis Alimentary Pharmacology & Therapeutics 2014 39 10 1113 25","DOI":"10.1111\/apt.12695"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0006|cit6","unstructured":"Dhiman R Khatri A Rana S Chopra M Thumburu K Malhotra S Probiotic preparation in the treatment of MHE - A double-blind, randomized, placebo controlled study Journal of Gastroenterology and Hepatology 2013 28 401 2"},{"issue":"5","key":"10.1002\/14651858.CD008716.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/030006058701500602","article-title":"Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study","volume":"15","author":"Loguercio","year":"1987","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0009|cit9","unstructured":"McGee R Request for clinical trial information [personal communication] Email to: C Loguercio"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0010|cit10","doi-asserted-by":"crossref","unstructured":"Loguercio C Abbiati R Rinaldi M Romano A Del Vecchio Blanco C Coltorti M Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy Journal of Hepatology 1995 23 1 39 46","DOI":"10.1016\/0168-8278(95)80309-2"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Lunia MK Sharma BC Srivastav S Sachdeva S Efficacy of probiotics on minimal hepatic encephalopathy and improvement in small intestinal bacterial overgrowth and orocecal transit time in cirrhosis: a randomised controlled trial Journal of Hepatology 2014 1 S246","DOI":"10.1016\/S0168-8278(14)60691-7"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/MEG.0b013e328330a8d3","article-title":"Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy","volume":"22","author":"Malaguarnera","year":"2010","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0013|cit13","unstructured":"McGee R Request for clinical trial information [personal communication] Email to: BC Sharma"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Mittal VV Sharma BC Sharma P Sarin SK A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy European Journal of Gastroenterology & Hepatology 2011 23 8 725 32","DOI":"10.1097\/MEG.0b013e32834696f5"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0015|cit15","first-page":"471A","article-title":"Treatment of minimal hepatic encephalopathy: a randomized controlled trial comparing lactulose, probiotics and L-ornithine L-aspartate with placebo","volume":"4 (Suppl)","author":"Mittal","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0016|cit16","doi-asserted-by":"crossref","unstructured":"Mouli VP Benjamin J Bhushan Singh M Mani K Garg SK Saraya A Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: a non-inferiority randomized controlled trial Hepatology Research 2015 45 8 880 9","DOI":"10.1111\/hepr.12429"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0017|cit17","unstructured":"Dalal R Request for clinical trial information [personal communication] Email to: RRS Nair"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0018|cit18","unstructured":"Nair RR Early detection of hepatic encephalopathy in preclinical stage with evoked response studies: a randomised control trial Neurology 2011 76 9 A222 3"},{"issue":"11","key":"10.1002\/14651858.CD008716.pub3-BIB0019|cit19","first-page":"A50","article-title":"Brainstem evoked response audiometry versus visual evoked response in detecting minimal hepatic encephalopathy and to assess the response after treatment with probiotics - A randomized double blind placebo controlled study","volume":"70","author":"Nair","year":"2008","journal-title":"American Academy of Neurology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0020|cit20","unstructured":"Nair RRS Jose J Thomas V BERA vs VEP in subclinical hepatic encephalopathy - A randomised control trial Annals of Neurology 2009 66 S28 9"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.nut.2010.01.006","article-title":"Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study","volume":"27","author":"Pereg","year":"2011","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0022|cit22","unstructured":"Clinical researches of bifid triple viable on the treatment of subclinical hepatic encephalopathy Chinese Journal of Clinical Gastroenterology 2010 22 2 105 6"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0023|cit23","doi-asserted-by":"crossref","unstructured":"Saji S Kumar S Thomas V A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy Tropical Gastroenterology 2011 32 2 128 32","DOI":"10.4103\/TROG_20113202_128"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0024|cit24","unstructured":"McGee R Request for clinical trial information [personal communication] Email to: BC Sharma"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/MEG.0b013e3282f3e6f5","article-title":"An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy","volume":"20","author":"Sharma","year":"2008","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0026|cit26","unstructured":"Sharma P Sharma BC Puri V Sarin SK A randomized control trial of lactulose versus probiotics versus lactulose plus probiotics in the treatment of minimal hepatic encephalopathy of cirrhosis 71st Annual Scientific Meeting of the American College of Gasroenterology, 2006 10 20-25, Las Vegas American College of Gastroenterology 2006 402"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0027|cit27","unstructured":"Pant S Dwivedi M Misra SP Narang S Sharma K Minimal hepatic encephalopathy: effect of rifaximin, probiotics and L-ornithine L-aspartate Indian Journal of Gastroenterology 2011 1 A51"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0028|cit28","unstructured":"Pant S Sharma K Misra SP Dwivedi M Narang S Mishra K Effect of rifaximin, probiotics and L-ornithine L-aspartate on minimal hepatic encephalopathy: a case control study Indian Journal of Gastroenterology 2013 1 A92"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0029|cit29","unstructured":"Sharma K Pant S Dwivedi M Misra SP Misra A Narang S Minimal hepatic encephalopathy: effect of rifaximin, probiotics and L-ornithine L-aspartate Journal of Gastroenterology and Hepatology 2012 27 275 6"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Sharma K Pant S Misra S Dwivedi M Misra A Narang S Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial Saudi Journal of Gastroenterology 2014 20 4 225 32","DOI":"10.4103\/1319-3767.136975"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0031|cit31","unstructured":"Shavakhi A Hashemi H Tabesh E Derakhshan Z Farzamnia S Meshkinfar S Multistrain probiotics and lactulose in the treatment of minimal hepatic encephalopathy Journal of Research in Medical Sciences 2014 19 8 703 8"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0032|cit32","doi-asserted-by":"crossref","unstructured":"Vlachogiannakos J Vasianopoulou P Viazis N Chroni M Karamanolis D Ladas SD Reversal of minimal hepatic encephalopathy after a probiotic administration. A prospective, randomized, placebo-controlled, double-blind study Journal of Hepatology 2016 64 Suppl 2 S165","DOI":"10.1016\/S0168-8278(16)01673-1"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0033|cit33","unstructured":"Vlachogiannakos J Vasianopoulou P Via-zis N Chroni M Voulgaris T Ladas SD The role of probiotics in the treatment of minimal hepatic encephalopathy. A prospective, randomized, placebo-controlled, double-blind study Hepatology (Baltimore, Md.) 2014 60 4 Suppl 376A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0034|cit34","unstructured":"Feng Q Zhang J A randomized-controlled trial to compare the effect of lactulose and probiotics on treatment of minimal hepatic encephalopathy Practical Journal of Clinical Medicine 2013 10 4 61 3"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0035|cit35","unstructured":"Zhitai Z Clinical application of probiotics in the treatment of hepatic encephalopathy Journal of Gastroenterology and Hepatology 2013 28 851"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Ziada DH Soliman HH Yamany SA Hamisa MF Hasan AM Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy Arab Journal of Gastroenterology 2013 14 3 116 22","DOI":"10.1016\/j.ajg.2013.08.002"},{"issue":"967","key":"10.1002\/14651858.CD008716.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/pgmj.2005.042200","article-title":"Treatment of non-alcoholic fatty liver disease","volume":"82","author":"Adams","year":"2006","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.14309\/00000434-201210001-00362","article-title":"Probiotics in minimal hepatic encephalopathy: a meta-analysis","volume":"107","author":"Agrawal","year":"2012","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0039|cit39","doi-asserted-by":"crossref","unstructured":"Agrawal A Sharma BC Sharma P Sarin SK Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy American Journal of Gastroenterology 2012 107 7 1043 50","DOI":"10.1038\/ajg.2012.113"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0040|cit40","doi-asserted-by":"crossref","unstructured":"Agrawal A Sharma BC Sharma P Sarin SK Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open label, randomized controlled trial of lactulose, probiotics and no-therapy Journal of Gastroenterology and Hepatology 2011 26 7","DOI":"10.1111\/j.1440-1746.2010.06596.x"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Agrawal A Sharma P Sharma B Sarin S Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open label, randomized controlled trial of lactulose, probiotics and no-therapy American Journal of Gastroenterology 2010 105 S105","DOI":"10.14309\/00000434-201010001-00282"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0042|cit42","unstructured":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open label, randomized controlled trial of lactulose, probiotics and no-therapy apps.who.int\/trialsearch\/Trial.aspx?TrialID=NCT01178372"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0043|cit43","first-page":"617","article-title":"Current trends in the treatment of hepatic encephalopathy","volume":"5","author":"Al Sibae","year":"2009","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0168-8278(02)00265-9","article-title":"Multifactorial gut barrier failure in cirrhosis and bacterial translocation: working out the role of probiotics and antioxidants","volume":"37","author":"Albillos","year":"2002","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Alisi A Bedogni G Baviera G Giorgio V Porro E Paris C Randomised clinical trial: the beneficial effects of VSL# 3 in obese children with non-alcoholic steatohepatitis Alimentary Pharmacology & Therapeutics 2014 39 11 1276 85","DOI":"10.1111\/apt.12758"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0046|cit46","unstructured":"Aller R De Luis DA Izaola O Conde R Gonzalez Sagrado M Primo D Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial European Review for Medical and Pharmacological Sciences 2011 15 9 1090 5"},{"issue":"10","key":"10.1002\/14651858.CD008716.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3748\/wjg.v12.i10.1493","article-title":"Gut flora and bacterial translocation in chronic liver disease","volume":"12","author":"Almeida","year":"2006","journal-title":"World Journal of Gastroenterology"},{"issue":"1011","key":"10.1002\/14651858.CD008716.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/pgmj.2009.079467","article-title":"Management of hepatic encephalopathy in children","volume":"86","author":"Arya","year":"2010","journal-title":"Postgraduate Medical Journal"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jgh.12142","article-title":"L-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials","volume":"28","author":"Bai","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"23","key":"10.1002\/14651858.CD008716.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.14.3609","article-title":"Minimal hepatic encephalopathy matters in daily life","volume":"14","author":"Bajaj","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1586\/17474124.2.6.785","article-title":"Management options for minimal hepatic encephalopathy","volume":"2","author":"Bajaj","year":"2008","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/apt.12756","article-title":"Commentary: Probing probiotics in cirrhosis - A template for future studies? Author's reply","volume":"39","author":"Bajaj","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.2010.04514.x","article-title":"Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children","volume":"33","author":"Barclay","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0054|cit54","first-page":"101","article-title":"Anti-endotoxin capacity and reticulo-endothelial function in alcohol-related liver cirrhosis: a randomized pilot study comparing a probiotic preparation versus lactulose","volume":"8","author":"Barreto-Zuniga","year":"2001","journal-title":"International Medical Journal"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2007-984575","article-title":"Emerging therapies for the management of hepatic encephalopathy","volume":"27","author":"Bass","year":"2007","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11011-008-9128-z","article-title":"Bio-ecological control of chronic liver disease and encephalopathy","volume":"24","author":"Bengmark","year":"2009","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0057|cit57","first-page":"309","article-title":"Bio-ecological control of chronic liver disease and encephalopathy","volume":"102","author":"Bengmark","year":"2011","journal-title":"Minerva Medica"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phrs.2012.09.002","article-title":"Gut microbiota, immune development and function","volume":"69","author":"Bengmark","year":"2013","journal-title":"Pharmacological Research"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MEG.0b013e3283417567","article-title":"Hepatic encephalopathy: from pathophysiology to therapeutic management","volume":"23","author":"Bismuth","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD008716.pub3-BIB0060|cit60","first-page":"324","article-title":"Complex therapy of chronic hepatic encephalopathy completed with probiotic: comparison of two studies","volume":"143","author":"Boca","year":"2004","journal-title":"Casopis Lekaru Ceskych"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mehy.2004.07.029","article-title":"Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy","volume":"64","author":"Bongaerts","year":"2005","journal-title":"Medical Hypotheses"},{"issue":"5","key":"10.1002\/14651858.CD008716.pub3-BIB0062|cit62","first-page":"545","article-title":"Nutrition in liver disease","volume":"8","author":"Cabre","year":"2005","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/qjmed\/hcp152","article-title":"Current concepts in the assessment and treatment of hepatic encephalopathy","volume":"103","author":"Cash","year":"2010","journal-title":"QJM : Monthly Journal of the Association of Physicians"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0884533610368712","article-title":"Nutrition in hepatic encephalopathy","volume":"25","author":"Chadalavada","year":"2010","journal-title":"Nutrition in Clinical Practice"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0065|cit65","first-page":"711","article-title":"Probiotics, prebiotics and synbiotics","volume":"3","author":"Chauhan","year":"2012","journal-title":"International Journal of Pharmaceutical Sciences and Research"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cgh.2011.08.016","article-title":"Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies","volume":"10","author":"Cheung","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0067|cit67","first-page":"52","article-title":"Tactics for the correction of intestinal microbiocenotic disorders in the combination therapy of patients with chronic liver diseases","volume":"86","author":"Chikhacheva","year":"2014","journal-title":"Terapevticheskii Arkhiv"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cgh.2012.03.024","article-title":"A gastroenterologist's guide to probiotics","volume":"10","author":"Ciorba","year":"2012","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0069|cit69","first-page":"397","article-title":"Oral bacteriotherapy with Bifidobacterium bifidum and Lactobacillus acidophilus in cirrhotic patients","volume":"131","author":"Colle","year":"1989","journal-title":"Clinica Terapeutica"},{"issue":"12","key":"10.1002\/14651858.CD008716.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1093\/ajcn\/23.12.1588","article-title":"Effects of lactulose and Lactobacillus acidophilus on the fecal flora","volume":"23","author":"Conn","year":"1970","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cld.190","article-title":"Management of patients with moderate alcoholic liver disease","volume":"2","author":"Crittenden","year":"2013","journal-title":"Clinical Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0072|cit72","unstructured":"Dai G Wu D Lian J Ma H Jiang B Clinical research on microecologic treatment combined enteral nutrition for hepatic encephalopathy Zhonghua Liu Xing Bing Xue Za Zhi 2014 35 12 1392 5"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0073|cit73","first-page":"S50","article-title":"Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics","volume":"22","author":"Dasarathy","year":"2003","journal-title":"Indian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11938-006-0003-x","article-title":"Hepatic encephalopathy: a review of its pathophysiology and treatment","volume":"9","author":"Dbouk","year":"2006","journal-title":"Current Treatment Options in Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0075|cit75","first-page":"41","article-title":"The possibilities of using probiotics in digestive diseases","volume":"16","author":"Demeter","year":"2006","journal-title":"Lege Artis Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0076|cit76","doi-asserted-by":"crossref","unstructured":"De Micco I D'Aniello R Sangermano M Mandato C Paolella G Lenta S A systematic review of pediatric NAFLD therapy: year 2012 Digestive and Liver Disease 2012 44 S288","DOI":"10.1016\/S1590-8658(12)60735-X"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1053\/j.gastro.2004.10.034","article-title":"Minimal hepatic encephalopathy: should we start treating it?","volume":"127","author":"Dhiman","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0078|cit78","first-page":"1","article-title":"Minimal hepatic encephalopathy: has the time come to recognize and treat it?","volume":"41","author":"Dhiman","year":"2007","journal-title":"Bulletin, Postgraduate Institute of Medical Education and Research, Chandigarh"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12664-009-0003-6","article-title":"Minimal hepatic encephalopathy","volume":"28","author":"Dhiman","year":"2009","journal-title":"Indian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1440-1746.2010.06318.x","article-title":"Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver","volume":"25","author":"Dhiman","year":"2010","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0081|cit81","unstructured":"Dhiman RK Rana BS Garg A Khattri A Chopra M Thumburu KK Efficacy and safety of a probiotic preparation in the secondary prophylaxis of hepatic encephalopathy in cirrhotic patients: interim results of a double blind, randomized, placebo controlled study Hepatology (Baltimore, Md.) 2012 56 255A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11011-013-9388-0","article-title":"Gut microbiota and hepatic encephalopathy","volume":"28","author":"Dhiman","year":"2013","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"Dhiman RK Rana B Agrawal S Garg A Chopra M Thumburu KK Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial Gastroenterology 2014 147 6 1327 37.e3","DOI":"10.1053\/j.gastro.2014.08.031"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0084|cit84","doi-asserted-by":"crossref","unstructured":"Dhiman RK Hepatic encephalopathy Journal of Clinical & Experimental Hepatology 2015 5 S1 S1 2","DOI":"10.1016\/j.jceh.2015.02.001"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/apt.12661","article-title":"Letter: probiotics vs. lactulose for minimal hepatic encephalopathy therapy","volume":"39","author":"Ding","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0086|cit86","unstructured":"Ding X Zhang FC Wang YJ Probiotics versus lactulose for minimal hepatic encephalopathy therapy: a randomized controlled trial meta-analysis Journal of Digestive Diseases 2014 15 135"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gtc.2005.05.011","article-title":"Lactobacillus GG: bacteriology and clinical applications","volume":"34","author":"Doron","year":"2005","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Druart C Alligier M Salazar N Neyrinck AM Delzenne NM Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties Advances in Nutrition 2014 5 5 624S 33S","DOI":"10.3945\/an.114.005835"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2174\/13816128113199990422","article-title":"Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders","volume":"20","author":"Dylag","year":"2014","journal-title":"Current Pharmaceutical Design"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0090|cit90","first-page":"S1","article-title":"47th Annual Meeting of the European Association for the Study of the Liver","volume":"56","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.amjsurg.2010.02.013","article-title":"Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study","volume":"201","author":"Eguchi","year":"2011","journal-title":"American Journal of Surgery"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0092|cit92","doi-asserted-by":"crossref","unstructured":"El-Nezami HS Polychronaki NN Ma J Zhu HL Ling WH Salminen EK Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China American Journal of Clinical Nutrition 2006 83 5 1199 203","DOI":"10.1093\/ajcn\/83.5.1199"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Eslamparast T Poustchi H Zamani F Sharafkhah M Malekzadeh R Hekmatdoost A Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study American Journal of Clinical Nutrition 2014 99 3 535 42","DOI":"10.3945\/ajcn.113.068890"},{"issue":"36","key":"10.1002\/14651858.CD008716.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.11569\/wcjd.v17.i36.3745","article-title":"Bifico improves intestinal macromolecular permeability in patients with liver cirrhosis","volume":"17","author":"Fan","year":"2009","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jgh.12244","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","author":"Fan","year":"2013","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0096|cit96","first-page":"58","article-title":"Hepatic encephalopathy and liver transplantation","volume":"65","author":"Fehervari","year":"2012","journal-title":"Magyar Sebeszet"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008716.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1055\/s-2001-14502","article-title":"Hepatic encephalopathy","volume":"126","author":"Ferenci","year":"2001","journal-title":"Deutsche Medizinische Wochenschrift"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-984574","article-title":"Treatment options for hepatic encephalopathy: a review","volume":"27","author":"Ferenci","year":"2007","journal-title":"Seminars in Liver Disease"},{"issue":"7","key":"10.1002\/14651858.CD008716.pub3-BIB0099|cit99","first-page":"210","article-title":"Rifaximin: a nonabsorbable, broad-spectrum antibiotic for reduction in the risk for recurrence of overt hepatic encephalopathy","volume":"45","author":"Feret","year":"2010","journal-title":"Formulary"},{"issue":"5","key":"10.1002\/14651858.CD008716.pub3-BIB0100|cit100","first-page":"554","article-title":"The impact of nutrition on cirrhotic patients awaiting liver transplantation","volume":"13","author":"Ferreira","year":"2010","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0101|cit101","doi-asserted-by":"crossref","unstructured":"Festi D Schiumerini R Eusebi LH Marasco G Taddia M Colecchia A Gut microbiota and metabolic syndrome World Journal of Gastroenterology 2014 20 43 16079 94","DOI":"10.3748\/wjg.v20.i43.16079"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00394-007-0666-7","article-title":"Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology","volume":"46","author":"Finney","year":"2007","journal-title":"European Journal of Nutrition"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0103|cit103","doi-asserted-by":"crossref","unstructured":"Floch MH Intestinal microbiota metabolism of a prebiotic to treat hepatic encephalopathy Clinical Gastroenterology and Hepatology 2015 13 1 209","DOI":"10.1016\/j.cgh.2014.06.008"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1017\/S0007114512004011","article-title":"Sources, isolation, characterisation and evaluation of probiotics","volume":"109","author":"Fontana","year":"2013","journal-title":"British Journal of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0105|cit105","first-page":"e7521","article-title":"Probiotic as a novel treatment strategy against liver disease","volume":"13","author":"Fooladi","year":"2013","journal-title":"Hepatitis Monthly"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccell.2010.04.007","article-title":"Current and emerging strategies for treating hepatic encephalopathy","volume":"22","author":"Foster","year":"2010","journal-title":"Critical Care Nursing Clinics of North America"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jhep.2008.09.006","article-title":"Probiotics for patients with liver cirrhosis","volume":"49","author":"Fujita","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0108|cit108","first-page":"26","article-title":"Probiotics and prebiotics in clinical practice","volume":"22","author":"Fuster","year":"2007","journal-title":"Nutricion Hospitilaria"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/1-4020-4456-9_44","volume-title":"Hepatic Encephalopathy and Nitrogen Metabolism","author":"Galhenage","year":"2006"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0110|cit110","doi-asserted-by":"crossref","unstructured":"Ganguli K Meng D Rautava S Lu L Walker WA Nanthakumar N Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation American Journal of Physiology. Gastrointestinal and Liver Physiology 2013 304 2 G132 41","DOI":"10.1152\/ajpgi.00142.2012"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0111|cit111","first-page":"372","article-title":"Importance of nutritional support in patients with hepatic encephalopathy","volume":"27","author":"Garcia","year":"2012","journal-title":"Nutricion Hospitalaria"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.3748\/wjg.v18.i46.6693","article-title":"Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota","volume":"18","author":"Garcovich","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"Gareau MG Microbiota-gut-brain axis and cognitive function Advances in Experimental Medicine and Biology 2014 817 357 71","DOI":"10.1007\/978-1-4939-0897-4_16"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11011-012-9372-0","article-title":"Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?","volume":"28","author":"Gluud","year":"2013","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0115|cit115","doi-asserted-by":"crossref","unstructured":"Gomez-Hurtado I Such J Sanz Y Frances R Gut microbiota-related complications in cirrhosis World Journal of Gastroenterology 2014 20 42 15624 31","DOI":"10.3748\/wjg.v20.i42.15624"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0116|cit116","unstructured":"Grat M Holowko W Galecka M Grat K Szachta P Lewandowski Z Gut microbiota in cirrhotic liver transplant candidates Hepato-Gastroenterology 2014 61 134 1661 7"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3748\/wjg.v16.i4.403","article-title":"Probiotics and gut health: a special focus on liver diseases","volume":"16","author":"Gratz","year":"2010","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD008716.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Greco","year":"2007","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0119|cit119","unstructured":"Gu L Yan S Li D Wang J Wang Q Effect of glutamine combined with probiotics on intestinal mucosal barrier and liver function in patients with liver cirrhosis Chinese Journal of Gastroenterology 2014 19 4 213 6"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajg.2009.03.001","article-title":"World Gastroenterology Organisation practice guideline: probiotics and prebiotics","volume":"10","author":"Guarner","year":"2009","journal-title":"Arab Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/MCG.0b013e3182549092","article-title":"World Gastroenterology Organisation global guidelines: probiotics and prebiotics October 2011","volume":"46","author":"Guarner","year":"2012","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S1665-2681(19)31866-6","article-title":"Intestinal flora, probiotics, and cirrhosis","volume":"7","author":"Guerrero","year":"2008","journal-title":"Annals of Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0123|cit123","unstructured":"Gupta N Kumar A Sharma B Sarin SK Addition of probiotics to propranolol improves response for primary prophylaxis of variceal bleeding in patients with cirrhosis and large esophageal varices Hepatology (Baltimore, Md.) 2010 52 1064A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0124|cit124","unstructured":"Gupta N Sarin SK Sharma BC Garg V Kumar A Addition of probiotics to propranolol improves response for primary prophylaxis of variceal bleeding in patients with cirrhosis and large esophageal varices Indian Journal of Gastroenterology 2010 1 A45"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0125|cit125","doi-asserted-by":"crossref","unstructured":"Gupta N Kumar A Sharma P Garg V Sharma BC Sarin SK Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial Liver International 2013 33 8 1148 57","DOI":"10.1111\/liv.12172"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0126|cit126","doi-asserted-by":"crossref","unstructured":"Hellinger WC Yao JD Alvarez S Blair JE Cawley JJ Paya CV A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation Transplantation 2002 73 12 1904 9","DOI":"10.1097\/00007890-200206270-00009"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.nut.2009.05.008","article-title":"Improvement of constipation and liver function by plant-derived lactic acid bacteria: a double-blind, randomized trial","volume":"26","author":"Higashikawa","year":"2010","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1872-034X.2012.01015.x","article-title":"Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy","volume":"42","author":"Holte","year":"2012","journal-title":"Hepatology Research"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1443-9611.2003.00110.x","article-title":"Effects of probiotics, lactitol and rifaximin on intestinal flora and fecal excretion of organic acids in cirrhotic patients","volume":"4","author":"Hotten","year":"2003","journal-title":"Chinese Journal of Digestive Diseases"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3920\/BM2010.0023","article-title":"Safety and persistence of orally administered human Lactobacillus sp. strains in healthy adults","volume":"2","author":"Hutt","year":"2011","journal-title":"Beneficial Microbes"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2174\/1389450115666140606111402","article-title":"Therapeutic modulation of gut microbiota: current clinical applications and future perspectives","volume":"15","author":"Ianiro","year":"2014","journal-title":"Current Drug Targets"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.clnu.2010.05.004","article-title":"Therapeutical use of probiotic formulations in clinical practice","volume":"29","author":"Iannitti","year":"2010","journal-title":"Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0133|cit133","first-page":"237","article-title":"Comparative study of portocaval encephalopathy treatment with lactulose, lactobacilli and antibiotics","volume":"47","author":"Imler","year":"1971","journal-title":"Therapeutique"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0134|cit134","doi-asserted-by":"crossref","unstructured":"Ivanovic N Minic R Djuricic I Dimitrijevic L Sobajic S Zivkovic I Brain and liver fatty acid composition changes upon consumption of Lactobacillus rhamnosus LA68 International Journal of Food Sciences and Nutrition 2015 66 1 93 7","DOI":"10.3109\/09637486.2014.979313"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clinre.2012.03.026","article-title":"Non-alcoholic fatty liver disease in children","volume":"36","author":"Janczyk","year":"2012","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0136|cit136","unstructured":"Jayakumar S Tandon P Bain V Ma MM Madsen K Bailey RJ Probiotics do not reduce portal pressure in patients with decompensated cirrhosis Hepatology (Baltimore, Md.) 2012 56 744A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0137|cit137","doi-asserted-by":"crossref","unstructured":"Jayakumar S Carbonneau M Hotte N Befus AD Owen R VSL#3 probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis Liver International 2013 33 10 1470 7","DOI":"10.1111\/liv.12280"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0138|cit138","first-page":"110","article-title":"Enteral feeding","volume":"20","author":"Jeejeebhoy","year":"2004","journal-title":"Critical Care Medicine"},{"issue":"9","key":"10.1002\/14651858.CD008716.pub3-BIB0139|cit139","first-page":"784","article-title":"Protective effect of compound tongfu granule on intestinal mucosal barrier in patients with cirrhosis of decompensation stage","volume":"28","author":"Jiang","year":"2008","journal-title":"Chinese Journal of Integrated Traditional and Western Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0140|cit140","doi-asserted-by":"crossref","unstructured":"Jones C Badger SA Regan M Clements BW Diamond T Parks RW Modulation of gut barrier function in patients with obstructive jaundice using probiotic LP299v European Journal of Gastroenterology & Hepatology 2013 25 12 1424 30","DOI":"10.1097\/MEG.0b013e328363e26e"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2036.2007.03480.x","article-title":"Review article: probiotics in gastrointestinal and liver diseases","volume":"26","author":"Jonkers","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0142|cit142","first-page":"105","article-title":"Treatment of hyperammonemia in liver failure","volume":"17","author":"Jover-Cobos","year":"2014","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0143|cit143","unstructured":"Jun DW Nam HH Moon JH Kim TY Sohn JH Koh DH Randomized clinical trial: Effects of multi-species probiotics on small intestinal bacterial overgrowth in patients with chronic liver disease - a placebo controlled study Hepatology (Baltimore, Md.) 2013 58 867A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0144|cit144","unstructured":"Jurado Garcia J Costan Rodero G Calanas-Continente A Importance of nutritional support in patients with hepatic encephalopathy Nutricion Hospitalaria 2012 27 2 372 81"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MOG.0b013e3283409c25","article-title":"Diet and cognition in chronic liver disease","volume":"27","author":"Kachaamy","year":"2011","journal-title":"Current Opinion in Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cld.2007.02.001","article-title":"Medical treatment of non-alcoholic steatohepatitis","volume":"11","author":"Kadayifci","year":"2007","journal-title":"Clinics in Liver Disease"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"G851","DOI":"10.1152\/ajpgi.00327.2009","article-title":"Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier","volume":"298","author":"Karczewski","year":"2010","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-984571","article-title":"Hepatic encephalopathy","volume":"27","author":"Keeffe","year":"2007","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cld.2012.03.009","article-title":"Hepatic encephalopathy","volume":"16","author":"Khungar","year":"2012","journal-title":"Clinics in Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0150|cit150","doi-asserted-by":"crossref","unstructured":"Kirpich IA Solovieva NV Leikhter SN Shidakova NA Lebedeva OV Sidorov PI Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study Alcohol 2008 42 8 675 82","DOI":"10.1016\/j.alcohol.2008.08.006"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0151|cit151","doi-asserted-by":"crossref","unstructured":"Kitagawa K Ishikawa H Oda T Saito H Morishita N Shimamoto K Development of combination therapy of bifidobacterium-based oral vaccine displaying HCV-NS3 with interferon-alpha Molecular Therapy 2015 23 S259","DOI":"10.1016\/S1525-0016(16)34259-9"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0152|cit152","doi-asserted-by":"crossref","unstructured":"Koga H Tamiya Y Mitsuyama K Ishibashi M Matsumoto S Imaoka A Probiotics promote rapid-turnover protein production by restoring gut flora in patients with alcoholic liver cirrhosis Hepatology International 2013 7 2 767 74","DOI":"10.1007\/s12072-012-9408-x"},{"issue":"28","key":"10.1002\/14651858.CD008716.pub3-BIB0153|cit153","first-page":"1252","article-title":"Intestine and liver-protective therapy","volume":"50","author":"Kremer","year":"1974","journal-title":"Zeitschrift f\u00fcr Allgemeinmedizin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008716.pub3-BIB0154|cit154","first-page":"S128","article-title":"Treatment of minimal hepatic encephalopathy","volume":"38","author":"Kumashiro","year":"2008","journal-title":"Hepatology Research"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0155|cit155","doi-asserted-by":"crossref","unstructured":"Kwak DS Jun DW Seo JG Chung WS Lee KN Short-term probiotic therapy alleviates small intestinal bacterial overgrowth, but does not improve intestinal permeability in chronic liver disease European Journal of Gastroenterology & Hepatology 2014 26 12 1353 9","DOI":"10.1097\/MEG.0000000000000214"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0156|cit156","first-page":"215","article-title":"Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis","volume":"52","author":"Lata","year":"2006","journal-title":"Vnitrni Lekarstvi"},{"issue":"12","key":"10.1002\/14651858.CD008716.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/MEG.0b013e3282efa40e","article-title":"The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study","volume":"19","author":"Lata","year":"2007","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0158|cit158","unstructured":"Lata J Jurankova J Fric P Pribramska V The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients - Results of double blind randomized study Gastroenterology 2007 132 4 A797 8"},{"issue":"Suppl","key":"10.1002\/14651858.CD008716.pub3-BIB0159|cit159","first-page":"A150","article-title":"The effects of probiotics on level of endotoxin in patients with liver disease - potential therapy of non alcoholic steatohepatitis?","volume":"1","author":"Lata","year":"2009","journal-title":"Journal of Diabetes"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.3748\/wjg.v17.i24.2890","article-title":"Probiotics in hepatology","volume":"17","author":"Lata","year":"2011","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0032-1301737","article-title":"Infectious complications of acute and chronic liver disease","volume":"33","author":"Leber","year":"2012","journal-title":"Seminars in Respiratory & Critical Care Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0162|cit162","unstructured":"Liboredo JC Abreu Ferrari MDL Vilela EG Lima AS Toulson Davisson Correia MI The effect of Saccharomyces boulardii in patients eligible for liver transplantation Nutricion Hospitalaria 2015 31 2 778 84"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0163|cit163","doi-asserted-by":"crossref","unstructured":"Use of lactobacillus casei rhamnosus to prevent cholangitis in biliary atresia after Kasai operation Journal of Pediatric Gastroenterology and Nutrition 2015 60 5 654 8","DOI":"10.1097\/MPG.0000000000000676"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.hepres.2003.11.005","article-title":"Endotoxinemia and benzodiazepine-like substances in compensated cirrhotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparation","volume":"28","author":"Lighthouse","year":"2004","journal-title":"Hepatology Research"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0165|cit165","unstructured":"Liu JS Tian Y Fu J Zhang XH Liu J Lin J Effects of probiotics agents treatment on the course of subclinical hepatic encephalopathy Chinese Journal of Postgraduates of Medicine 2006 29 1C 12 4"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0166|cit166","unstructured":"Liu W Effect of administration of Medilac-S probiotics on endo-toxemia and hepatic encephalopathy Chinese Medicine of Factory and Mine 2009 22 3 296 7"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/NNR.0b013e3181fa4dc6","article-title":"Probiotic yogurt effects on intestinal flora of patients with chronic liver disease","volume":"59","author":"Liu","year":"2010","journal-title":"Nursing Research"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00284-012-0105-8","article-title":"Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals","volume":"65","author":"Liu","year":"2012","journal-title":"Current Microbiology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0169|cit169","doi-asserted-by":"crossref","unstructured":"Llorente C Schnabl B The gut microbiota and liver disease Cellular and Molecular Gastroenterology and Hepatology 2015 1 3 275 84","DOI":"10.1016\/j.jcmgh.2015.04.003"},{"issue":"8","key":"10.1002\/14651858.CD008716.pub3-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1572-0241.2002.05942.x","article-title":"Gut-liver axis: a new point of attack to treat chronic liver damage?","volume":"97","author":"Loguercio","year":"2002","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.mcg.0000165671.25272.0f","article-title":"Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases","volume":"39","author":"Loguercio","year":"2005","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0172|cit172","doi-asserted-by":"crossref","unstructured":"Louvet A Mathurin P Alcoholic liver disease: Mechanisms of injury and targeted treatment Nature Reviews. Gastroenterology & Hepatology 2015 12 4 231 42","DOI":"10.1038\/nrgastro.2015.35"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00248-010-9801-8","article-title":"Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients","volume":"61","author":"Lu","year":"2011","journal-title":"Microbial Ecology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0174|cit174","unstructured":"Luna LEM Fafutis-Morris M Segura-Ortega JE Delgado V Zuniga-Partida V Prebiotic vs symbiotic to decrease ammonium levels in cirrhotic patients with and without minimal hepatic encephalopathy Hepatology (Baltimore, Md.) 2010 52 919A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0175|cit175","doi-asserted-by":"crossref","unstructured":"Lunia MK Sachdeva S Srivastava S Sharma BC An open label randomised controlled trial of probiotics for primary prophylaxis of hepatic encephalopathy in patients with cirrhosis Journal of Gastroenterology and Hepatology 2012 27 241","DOI":"10.1016\/S0168-8278(13)60080-X"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0176|cit176","doi-asserted-by":"crossref","unstructured":"Lunia MK Sharma BC Sachdeva S Srivastava S An open label randomised controlled trial of probiotics for primary prophylaxis of hepatic encephalopathy in patients with cirrhosis Journal of Hepatology 2013 58 S35","DOI":"10.1016\/S0168-8278(13)60080-X"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0177|cit177","doi-asserted-by":"crossref","unstructured":"Lunia MK Sharma BC Sharma P Sachdeva S Srivastava S Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial Clinical Gastroenterology and Hepatology 2014 12 6 1003 8.e1","DOI":"10.1016\/j.cgh.2013.11.006"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/MEG.0b013e32834d1938","article-title":"Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis","volume":"23","author":"Luo","year":"2011","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.3748\/wjg.v19.i40.6911","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis","volume":"19","author":"Ma","year":"2013","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1665-2681(19)31457-7","article-title":"Gut microbiota and nonalcoholic fatty liver disease","volume":"11","author":"Machado","year":"2012","journal-title":"Annals of Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD008716.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1097\/MCG.0b013e31817283cb","article-title":"Probiotics in critically ill patients","volume":"42","author":"Madsen","year":"2008","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0182|cit182","doi-asserted-by":"crossref","unstructured":"Malaguarnera M Greco F Barone G Gargante MP Malaguarnera M Toscano MA Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study Digestive Diseases and Sciences 2007 52 11 3259 65","DOI":"10.1007\/s10620-006-9687-y"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0183|cit183","doi-asserted-by":"crossref","unstructured":"Malaguarnera M Vacante M Antic T Giordano M Chisari G Acquaviva R Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis Digestive Diseases and Sciences 2012 57 2 545 53","DOI":"10.1007\/s10620-011-1887-4"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/clnu.2001.0403","article-title":"Prebiotics and probiotics for gastrointestinal health","volume":"20","author":"Marteau","year":"2001","journal-title":"Clinical Nutrition"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1079\/BJN2002531","article-title":"Nutritional advantages of probiotics and prebiotics","volume":"87","author":"Marteau","year":"2002","journal-title":"British Journal of Nutrition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008716.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1054\/clnu.2001.0403","article-title":"Prebiotics and probiotics for gastrointestinal health","volume":"20","author":"Marteu","year":"2001","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pop.2010.02.003","article-title":"Integrative medicine and gastrointestinal disease","volume":"37","author":"Michelfelder","year":"2010","journal-title":"Primary Care - Clinics in Office Practice"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0188|cit188","doi-asserted-by":"crossref","unstructured":"Minemura M Shimizu Y Gut microbiota and liver diseases World Journal of Gastroenterology 2015 21 6 1691 702","DOI":"10.3748\/wjg.v21.i6.1691"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0189|cit189","first-page":"1042","article-title":"Probiotics: an approach for better treatment","volume":"3","author":"Mishra","year":"2012","journal-title":"Research Journal of Pharmaceutical, Biological and Chemical Sciences"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1345\/aph.1R146","article-title":"Combination therapy for the treatment and prevention of hepatic encephalopathy","volume":"46","author":"Mohammad","year":"2012","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/MEG.0b013e328351048e","article-title":"What type of probiotic was used?","volume":"24","author":"Montagnese","year":"2012","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11894-010-0150-z","article-title":"Advances in the evaluation and management of minimal hepatic encephalopathy","volume":"13","author":"Montgomery","year":"2011","journal-title":"Current Gastroenterology Reports"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/01.mcg.0000165649.32371.71","article-title":"Probiotics used in human studies","volume":"39","author":"Montrose","year":"2005","journal-title":"Journal of Clinical Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0194|cit194","first-page":"346","article-title":"Oral supplementation of symbiotic to decrease ammonium levels in cirrhotic patients with or without minimal hepatic encephalopathy","volume":"5","author":"Moreno-Luna","year":"2011","journal-title":"Hepatology International"},{"issue":"3-4","key":"10.1002\/14651858.CD008716.pub3-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11011-007-9060-7","article-title":"The treatment of hepatic encephalopathy","volume":"22","author":"Morgan","year":"2007","journal-title":"Metabolic Brain Disease"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008716.pub3-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-2007-984576","article-title":"An algorithm for the management of hepatic encephalopathy","volume":"27","author":"Mullen","year":"2007","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0197|cit197","doi-asserted-by":"crossref","unstructured":"Nabavi S Rafraf M Somi MH Homayouni-Rad A Asghari-Jafarabadi M Effects of probiotic yogurt consumption on metabolic factors in individuals with nonalcoholic fatty liver disease Journal of Dairy Science 2014 97 12 7386 93","DOI":"10.3168\/jds.2014-8500"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0198|cit198","first-page":"282","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open label, randomized controlled trial of lactulose, probiotics and no-therapy","volume":"105","author":"Nazir","year":"2010","journal-title":"American Congress of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0199|cit199","unstructured":"Hyperproteic and fiber-rich diet plus probiotics (lactobacillus reuteri) and nitazoxanide in the treatment of minimal hepatic encephalopathy clinicaltrials.gov\/ct2\/show\/NCT01135628"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0200|cit200","unstructured":"Olveira Fuster G Gonzalez-Molero I Probiotics and prebiotics in clinical practice Nutricion Hospitalaria 2007 22 26 34"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ajg.2009.593","article-title":"Alcoholic liver disease","volume":"105","author":"Oshea","year":"2010","journal-title":"American Journal of Gastroenterology"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD008716.pub3-BIB0202|cit202","first-page":"454A","article-title":"Addition of probiotics to antibiotics does not improve its efficacy in prevention of spontaneous bacterial peritonitis: a double blind placebo-controlled randomized controlled trial","volume":"50","author":"Pande","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0203|cit203","doi-asserted-by":"crossref","unstructured":"Pande C Kumar A Sarin SK Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: A double-blind placebo-controlled randomized-controlled trial European Journal of Gastroenterology & Hepatology 2012 24 7 831 9","DOI":"10.1097\/MEG.0b013e3283537d61"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0204|cit204","doi-asserted-by":"crossref","unstructured":"Paolella G Mandato C Pierri L Poeta M Di Stasi M Vajro P Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease World Journal of Gastroenterology 2014 20 42 15518 31","DOI":"10.3748\/wjg.v20.i42.15518"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gtc.2007.03.001","article-title":"Prebiotics, probiotics, and dietary fiber in gastrointestinal disease","volume":"36","author":"Park","year":"2007","journal-title":"Gastroenterology Clinics of North America"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0206|cit206","doi-asserted-by":"crossref","unstructured":"Patel R Dupont HL New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics Clinical Infectious Diseases 2015 60 S108 21","DOI":"10.1093\/cid\/civ177"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0207|cit207","unstructured":"Pawar R Pardeshi M Ghongane B Study of effects of probiotic lactobacilli in preventing major complications in patients of liver cirrhosis International Journal of Research in Pharmaceutical and Biomedical Sciences 2012 3 1 206 11"},{"issue":"9","key":"10.1002\/14651858.CD008716.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2165\/10898630-000000000-00000","article-title":"Pharmacotherapy for hepatic encephalopathy","volume":"70","author":"Phongsamran","year":"2010","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0209|cit209","doi-asserted-by":"crossref","unstructured":"Plaza-Diaz J Gomez-Llorente C Abadia-Molina F Saez-Lara MJ Campana-Martin L Munoz-Quezada S Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in zucker rats PLoS ONE 2014 9 5 9","DOI":"10.1371\/journal.pone.0098401"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"480309","DOI":"10.1155\/2012\/480309","article-title":"A current review of the diagnostic and treatment strategies of hepatic encephalopathy","volume":"2012","author":"Poh","year":"2012","journal-title":"International Journal of Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0211|cit211","unstructured":"Poustchi H Eslamparast T Zamani F Sharafkhah M Eghtesad S Malekzadeh R Effects of synbiotic supplementation on nonalcoholic fatty liver disease Journal of Gastroenterology and Hepatology 2013 28 850 1"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.clinthera.2013.07.421","article-title":"Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis","volume":"35","author":"Prakash","year":"2013","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1053\/j.gastro.2005.11.046","article-title":"Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics","volume":"130","author":"Quigley","year":"2006","journal-title":"Gastroentrology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jhep.2012.11.023","article-title":"The gut microbiota and the liver. Pathophysiological and clinical implications","volume":"58","author":"Quigley","year":"2013","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/apt.12751","article-title":"Commentary: Probing probiotics in cirrhosis - A template for future studies?","volume":"39","author":"Quigley","year":"2014","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-0897-4_19","article-title":"The future of probiotics for disorders of the brain-gut axis","volume":"817","author":"Quigley","year":"2014","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e328351d003","article-title":"Complications of cirrhosis","volume":"28","author":"Rahimi","year":"2012","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/MOG.0b013e32835f43b0","article-title":"End-stage liver disease complications","volume":"29","author":"Rahimi","year":"2013","journal-title":"Current Opinion in Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0219|cit219","doi-asserted-by":"crossref","unstructured":"Rayes N Brammer M Hansen S Mueller AR Serke S Seehofer D Early enteral supply of lactobacilli and fibre versus SBD - A prospective randomised trial in liver transplant recipients Journal of Hepatology 2001 34 199","DOI":"10.1016\/S0168-8278(01)81608-1"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00007890-200207150-00021","article-title":"Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients","volume":"74","author":"Rayes","year":"2002","journal-title":"Transplantation"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0221|cit221","doi-asserted-by":"crossref","unstructured":"Rayes N Seehofer D Theruvath T Schiller RA Langrehr JM Jonas S Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - A randomized, double-blind trial American Journal of Transplantation 2005 5 1 125 30","DOI":"10.1111\/j.1600-6143.2004.00649.x"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0222|cit222","doi-asserted-by":"crossref","unstructured":"Rayes N Pilarski T Stockmann M Bengmark S Neuhaus P Seehofer D Effect of pre- and probiotics on liver regeneration after resection: a randomised, double-blind pilot study Beneficial Microbes 2012 3 3 237 44","DOI":"10.3920\/BM2012.0006"},{"issue":"5498","key":"10.1002\/14651858.CD008716.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/bmj.1.5498.1267","article-title":"Lactobacillus acidophilus (Enpac) in treatment of hepatic encephalopathy","volume":"1","author":"Read","year":"1966","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/nu5030679","article-title":"Role of probiotics in short bowel syndrome in infants and children - a systematic review","volume":"5","author":"Reddy","year":"2013","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0225|cit225","unstructured":"Rifatbegovic Z Mesic D Ljuca F Zildzic M Avdagic M Grbic K Effect of probiotics on liver function after surgery resection for malignancy in the liver cirrhotic Medicinski Arhiv 2010 64 4 208 11"},{"issue":"3","key":"10.1002\/14651858.CD008716.pub3-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14728210903055067","article-title":"Emerging drugs for hepatic encephalopathy","volume":"14","author":"Riggio","year":"2009","journal-title":"Expert Opinion on Emerging Drugs"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0227|cit227","doi-asserted-by":"crossref","unstructured":"Rincon D Vaquero J Hernando A Galindo E Ripoll C Puerto M Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites Liver International 2014 34 10 1504 12","DOI":"10.1111\/liv.12539"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/08910600601178709","article-title":"Synbiotic-associated improvement in liver function in cirrhotic patients: relation to changes in circulating cytokine messenger RNA and protein levels","volume":"19","author":"Riordan","year":"2007","journal-title":"Microbial Ecology in Health and Disease"},{"issue":"12","key":"10.1002\/14651858.CD008716.pub3-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMe1000850","article-title":"Gut flora and hepatic encephalopathy in patients with cirrhosis","volume":"362","author":"Riordan","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.clinthera.2011.06.007","article-title":"Rifaximin: new therapeutic indication and future directions","volume":"33","author":"Rivkin","year":"2011","journal-title":"Clinical Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD008716.pub3-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1517\/14656561003724721","article-title":"Pharmacotherapy of hepatic encephalopathy in cirrhosis","volume":"11","author":"Romero-Gomez","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0232|cit232","doi-asserted-by":"crossref","unstructured":"Sanchez E Nieto JC Boullosa A Vidal S Sancho FJ Rossi G VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis Liver International 2015 35 3 735 45","DOI":"10.1111\/liv.12566"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0233|cit233","first-page":"105","article-title":"Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?","volume":"129","author":"Scevola","year":"1989","journal-title":"Clinica Terapeutica"},{"issue":"5 pt 2","key":"10.1002\/14651858.CD008716.pub3-BIB0234|cit234","first-page":"16S","article-title":"Treatment options for hepatic encephalopathy","volume":"30","author":"Schiano","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0235|cit235","doi-asserted-by":"crossref","unstructured":"Schuster-Wolff-B\u00fchring R Fischer L Hinrichs J Production and physiological action of the disaccharide lactulose International Dairy Journal 2010 20 11 731 41","DOI":"10.1016\/j.idairyj.2010.05.004"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.idairyj.2010.05.004","article-title":"Production and physiological action of the disaccharide lactulose","volume":"20","author":"Schuster-Wolff-B\u00fchring","year":"2010","journal-title":"International Dairy Journal"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0237|cit237","unstructured":"Segura-Ortega JE Moreno-Luna LE Delgado V Zuniga-Partida V Fafutis-Morris M Decrease in ammonium levels and increase in the neutrophils phagocytic capacity in cirrhotic patients after the ingestion of agave inulin and a probiotic mixture of bifidobacterias and lactobillus Hepatology (Baltimore, Md.) 2010 52 917A"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0238|cit238","doi-asserted-by":"crossref","unstructured":"Shang XJ Effect of treatment with compound Lactobacillus acidophilus on complements and T lymphocyte subsets in patients with compensated liver cirrhosis World Chinese Journal of Digestology 2013 21 24 2446 50","DOI":"10.11569\/wcjd.v21.i24.2446"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0239|cit239","doi-asserted-by":"crossref","unstructured":"Sharma BC Minimal hepatic encephalopathy Hepatology International 2010 4 1 46","DOI":"10.1016\/S0973-6883(11)60091-1"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1440-1746.2012.07186.x","article-title":"Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labelled randomized controlled trial of lactulose versus no lactulose","volume":"27","author":"Sharma","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0241|cit241","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11011-013-9392-4","article-title":"Disaccharides in the treatment of hepatic encephalopathy","volume":"28","author":"Sharma","year":"2013","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0242|cit242","doi-asserted-by":"crossref","unstructured":"Sharma M Bhat S Dutt K Sharma P Bhat JA Randomized controlled trial of lactulose and lactulose plus probiotics in the treatment of minimal hepatic encephalopathy Journal of Evidence Based Medicine and Healthcare 2014 1 9 1125 36","DOI":"10.18410\/jebmh\/2014\/166"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0243|cit243","doi-asserted-by":"crossref","unstructured":"Sharma P Sharma BC A survey of patterns of practice and perception of minimal hepatic encephalopathy: a nationwide survey in India Saudi Journal of Gastroenterology 2014 20 5 304 8","DOI":"10.4103\/1319-3767.141692"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0244|cit244","doi-asserted-by":"crossref","unstructured":"Sharma BC Maharshi S Prevention of hepatic encephalopathy recurrence Clinical Liver Disease 2015 5 3 64 7","DOI":"10.1002\/cld.446"},{"issue":"9457","key":"10.1002\/14651858.CD008716.pub3-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(05)70239-7","article-title":"Dispelling myths in the treatment of hepatic encephalopathy","volume":"365","author":"Shawcross","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0246|cit246","unstructured":"Shen Z Ma L Zhang W Gao S Curative effect observation of lactobacillus acidophilus complex combined fiberform in treatment of hepatic encephalopathy Chinese Journal of Microecology 2013 25 679 81"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0247|cit247","first-page":"2505","article-title":"Effects of micro-ecological agents on intestinal flora and blood ammonia of patients with hepatic encephalopathy","volume":"10","author":"Shen","year":"2014","journal-title":"Chinese Journal of Nosocomiology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/MCG.0b013e318169c44e","article-title":"Probiotics and liver disease","volume":"42","author":"Sheth","year":"2008","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0249|cit249","unstructured":"Shu M Che YG Curative effects of bacillus licheniformis capsule on course of subclinical hepatic encephalopathy Chinese Journal of General Practice 2008 16 1119 20"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0250|cit250","first-page":"385","article-title":"Effects of use of probiotics in minimal hepatic encephalopathy: a meta-analysis of randomized controlled trials","volume":"104","author":"Shukla","year":"2009","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0251|cit251","first-page":"S818","article-title":"Comparison of probiotics and lactulose as treatment options in hepatic encephalopathy: a meta-analysis","volume":"1","author":"Shukla","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0252|cit252","first-page":"S777","article-title":"Use of prebiotics, probiotics and synbiotics in treatment of minimal hepatic encephalopathy: a meta-analysis","volume":"1","author":"Shukla","year":"2010","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0253|cit253","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","article-title":"Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy","volume":"33","author":"Shukla","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-9877(03)00192-0","article-title":"Probiotics can treat hepatic encephalopathy","volume":"61","author":"Solga","year":"2003","journal-title":"Medical Hypotheses"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/liv.12288","article-title":"Probiotics in cirrhosis: do we expect too much?","volume":"33","author":"Soriano","year":"2013","journal-title":"Liver International"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0256|cit256","first-page":"558","article-title":"Probiotics in liver diseases","volume":"28","author":"Soriano","year":"2013","journal-title":"Nutricion Hospitalaria"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","article-title":"Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis","volume":"48","author":"Stadlbauer","year":"2008","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD008716.pub3-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncpgasthep0999","article-title":"Minimal hepatic encephalopathy","volume":"4","author":"Stewart","year":"2007","journal-title":"Nature Clinical Practice. Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1440-1746.2011.06830.x","article-title":"Nutritional considerations in end-stage liver disease","volume":"26","author":"Strasser","year":"2011","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0260|cit260","doi-asserted-by":"crossref","unstructured":"Suk KT Sohn KM Kim YD Cheon GJ Choi DH Kim MY Effect of probiotics (cultured lactobacillus subtilis\/streptococcus faecium) in the treatment of alcoholic hepatitis: randomized controlled multicenter study Hepatology (Baltimore, Md.) 2012 56 590A","DOI":"10.1016\/S0168-8278(12)61383-X"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.mcna.2009.03.009","article-title":"Hepatic encephalopathy: pathophysiology and emerging therapies","volume":"93","author":"Sundaram","year":"2009","journal-title":"Medical Clinics of North America"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0262|cit262","first-page":"2587","article-title":"Efficacy of probiotics in the treatment of minimal hepatic encephalopathy: a meta analysis","volume":"19","author":"Tang","year":"2011","journal-title":"World Chinese Journal of Digestology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0263|cit263","doi-asserted-by":"crossref","unstructured":"Tapper EB Jiang G Patwardhan VR Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy Mayo Clinic Proceedings 2015 90 5 646 58","DOI":"10.1016\/j.mayocp.2015.03.003"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0264|cit264","doi-asserted-by":"crossref","unstructured":"Tarantino G Finelli C Systematic review on intervention with prebiotics\/probiotics in patients with obesity-related nonalcoholic fatty liver disease Future Microbiology 2015 10 5 889 902","DOI":"10.2217\/fmb.15.13"},{"issue":"7","key":"10.1002\/14651858.CD008716.pub3-BIB0265|cit265","first-page":"1037","article-title":"Effects of lactitol on fecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy","volume":"92","author":"Tarao","year":"1995","journal-title":"Nippon Shokakibyo Gakkai Zasshi"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0266|cit266","doi-asserted-by":"crossref","unstructured":"Tojo R Suarez A Clemente MG de los Reyes-Gavilan CG Margolles A Gueimonde M Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis World Journal of Gastroenterology 2014 20 41 15163 76","DOI":"10.3748\/wjg.v20.i41.15163"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"RA53","DOI":"10.12659\/MSM.881387","article-title":"Hepatic encephalopathy: an updated approach from pathogenesis to treatment","volume":"17","author":"Toris","year":"2011","journal-title":"Medical Science Monitor"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.25915","article-title":"New therapeutic paradigm for patients with cirrhosis","volume":"56","author":"Tsochatzis","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1586\/17474124.2014.902303","article-title":"Future treatments of cirrhosis","volume":"8","author":"Tsochatzis","year":"2014","journal-title":"Expert Review of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0270|cit270","first-page":"76","article-title":"Probiotics: a review","volume":"19","author":"Upadhyay","year":"2012","journal-title":"Journal of Clinical Outcomes Management"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0271|cit271","doi-asserted-by":"crossref","unstructured":"Usami M Miyoshi M Kanbara Y Aoyama M Sakaki H Shuno K Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis Journal of Parenteral and Enteral Nutrition 2011 35 3 317 28","DOI":"10.1177\/0148607110379813"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0272|cit272","doi-asserted-by":"crossref","unstructured":"Valentini L Pinto A Bourdel-Marchasson I Ostan R Brigidi P Turroni S Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The \"RISTOMED project\": Randomized controlled trial in healthy older people Clinical Nutrition 2015 34 4 593 602","DOI":"10.1016\/j.clnu.2014.09.023"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0273|cit273","doi-asserted-by":"crossref","unstructured":"Videhult FK Ohlund I Stenlund H Hernell O West CE Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age European Journal of Nutrition 2015 54 3 355 63","DOI":"10.1007\/s00394-014-0715-y"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0274|cit274","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0275|cit275","doi-asserted-by":"crossref","unstructured":"Vilstrup H Amodio P Bajaj J Ferenci P Mullen KD Weissenborn K Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases Journal of Hepatology 2014 61 3 642 59","DOI":"10.1016\/j.jhep.2014.05.042"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0276|cit276","doi-asserted-by":"crossref","first-page":"872716","DOI":"10.1155\/2012\/872716","article-title":"Probiotics, prebiotics, and synbiotics: gut and beyond","volume":"2012","author":"Vyas","year":"2012","journal-title":"Gastroenterology Research and Practice"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0277|cit277","first-page":"55","article-title":"Optimal treatment of hepatic encephalopathy","volume":"60","author":"Waghray","year":"2014","journal-title":"Minerva Gastroenterologica e Dietologica"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0278|cit278","doi-asserted-by":"crossref","unstructured":"Waghray A Waghray N Mullen K Management of covert hepatic encephalopathy Journal of Clinical and Experimental Hepatology 2015 5 S1 S75 81","DOI":"10.1016\/j.jceh.2014.02.007"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0279|cit279","unstructured":"Wang XY Qu CM Liang SW Cao YJ Li LY Zhong CQ Efficacy analysis on treatment of subclinical hepatic encephalopathy by live combined bacillus subtilis and enterococcus faecium enteric-coated capsules Progress in Modern Biomedicine 2012 12 6489 91"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0280|cit280","first-page":"17","article-title":"Effect of probiotics in improvement of minimal hepatic encephalopathy in cirrhosis patients with hepatitis B virus","volume":"2","author":"Wang","year":"2015","journal-title":"Medical & Pharmaceutical Journal of Chinese People's Liberation Army"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0281|cit281","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/SGA.0b013e31825ad583","article-title":"Improving treatments for hepatic encephalopathy","volume":"35","author":"Welliver","year":"2012","journal-title":"Gastroenterology Nursing"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0282|cit282","doi-asserted-by":"crossref","unstructured":"Wong VWS Wong GLH Chim AML Chu WCW Yeung DKW Li KCT Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study Annals of Hepatology 2013 12 2 256 62","DOI":"10.1016\/S1665-2681(19)31364-X"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0283|cit283","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cld.2012.08.007","article-title":"Long-term management of alcoholic liver disease","volume":"16","author":"Woo","year":"2012","journal-title":"Clinics in Liver Disease"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0284|cit284","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpg.2006.07.009","article-title":"Management of hepatic encephalopathy in patients with cirrhosis","volume":"21","author":"Wright","year":"2007","journal-title":"Best Practice and Research in Clinical Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0285|cit285","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3748\/wjg.14.313","article-title":"Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats","volume":"14","author":"Wu","year":"2008","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0286|cit286","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00248-011-9925-5","article-title":"Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease","volume":"63","author":"Xu","year":"2012","journal-title":"Microbial Ecology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0287|cit287","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1499-3872(14)60280-0","article-title":"Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials","volume":"13","author":"Xu","year":"2014","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0288|cit288","doi-asserted-by":"crossref","unstructured":"Xu M Chang B Mathews S Gao B New drug targets for alcoholic liver disease Hepatology International 2014 8 2 475 80","DOI":"10.1007\/s12072-014-9516-x"},{"issue":"10","key":"10.1002\/14651858.CD008716.pub3-BIB0289|cit289","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.fct.2009.07.001","article-title":"Safety assessment of Lactobacillus brevis KB290 as a probiotic strain","volume":"47","author":"Yakabe","year":"2009","journal-title":"Food and Chemical Toxicology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0290|cit290","unstructured":"Yao XM Qu JG Lin AB Li HW Effect of probiotics on non-alcoholic fatty liver disease Journal of International Pharmaceutical Research 2014 41 5 548 51"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0291|cit291","doi-asserted-by":"crossref","first-page":"859697","DOI":"10.1155\/2012\/859697","article-title":"Nutrition therapy for liver diseases based on the status of nutritional intake","volume":"2012","author":"Yasutake","year":"2012","journal-title":"Gastroenterology Research and Practice"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0292|cit292","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/ACO.0b013e32833724c3","article-title":"Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure","volume":"23","author":"Zafirova","year":"2010","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0293|cit293","first-page":"30","article-title":"Probiotic bacterium Lactobacillus rhamnosus: beneficial and adverse effects on human health","volume":"67","author":"Zamberlin","year":"2012","journal-title":"Milchwissenschaft - Milk Science International"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0294|cit294","first-page":"25","article-title":"Efficacy of probiotics in treating liver cirrhosis: a meta analysis","volume":"19","author":"Zhang","year":"2014","journal-title":"Chinese Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0295|cit295","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1443-9573.2004.00157.x","article-title":"Intestinal microflora in patients with liver cirrhosis","volume":"5","author":"Zhao","year":"2004","journal-title":"Chinese Journal of Digestive Diseases"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0296|cit296","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11124\/jbisrir-2014-1261","article-title":"Optimal medical management of minimal hepatic encephalopathy: a systematic review protocol","volume":"12","author":"Zucker","year":"2014","journal-title":"JBI Database of Systematic Reviews and Implementation Reports"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0297|cit297","unstructured":"The effects of synbiotics, branched chain amino acids on hepatic encephalopathy apps.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12610001021066"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0298|cit298","unstructured":"Effects of probiotics on the level of consciousness in patients with hepatic encephalopathy apps.who.int\/trialsearch\/Trial2.aspx?TrialID=IRCT201211012417N9"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0299|cit299","unstructured":"Minimal hepatic encephalopathy in childhood and young adult: epidemiological study and pilot interventional study clinicaltrials.gov\/ct2\/show\/NCT01798329"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0300|cit300","doi-asserted-by":"crossref","unstructured":"Allampati S Mullen KD Nomenclature and definition of hepatic encephalopathy - An update Clinical Liver Disease 2015 5 3 68 70","DOI":"10.1002\/cld.449"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0301|cit301","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939","article-title":"Branched-chain amino acids for hepatic encephalopathy","author":"Als-Nielsen","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0302|cit302","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002798.pub2","article-title":"Benzodiazepine receptor antagonists for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0303|cit303","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0304|cit304","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003047.pub2","article-title":"Dopaminergic agonists for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0305|cit305","first-page":"1472","article-title":"Comparing several groups using analysis of variance","volume":"312","author":"Altman","year":"1996","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0306|cit306","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis","volume":"48","author":"Arguedas","year":"2003","journal-title":"Digestive Diseases and Sciences"},{"issue":"7","key":"10.1002\/14651858.CD008716.pub3-BIB0307|cit307","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy \u2013 an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0308|cit308","doi-asserted-by":"crossref","unstructured":"Bass NM Mullen KD Sanyal A Poordad F Neff G Leevy CB Rifaximin treatment in hepatic encephalopathy New England Journal of Medicine 2010 362 12 1071 81","DOI":"10.1056\/NEJMoa0907893"},{"issue":"9613","key":"10.1002\/14651858.CD008716.pub3-BIB0309|cit309","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(08)60207-X","article-title":"Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial","volume":"371","author":"Besselink","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0310|cit310","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0311|cit311","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36\u00ae Health Survey Questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0312|cit312","first-page":"1","article-title":"Ammonia: key factor in the pathogenesis of hepatic encephalopathy","volume":"6","author":"Butterworth","year":"1987","journal-title":"Molecular and Chemical Neuropathology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0313|cit313","doi-asserted-by":"crossref","unstructured":"Conn H Leevy C Vlahcevic Z Rodgers J Maddrey W Seeff L Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial Gastroenterology 1977 72 4 (Pt 1) 573 83","DOI":"10.1016\/S0016-5085(77)80135-2"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0314|cit314","doi-asserted-by":"crossref","unstructured":"De Preter V Vanhoutte T Huys G Swings J Rutgeerts P Verbeke K Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects Alimentary Pharmacology & Therapeutics 2006 23 7 963 74","DOI":"10.1111\/j.1365-2036.2006.02834.x"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0315|cit315","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy - Definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congress of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"9","key":"10.1002\/14651858.CD008716.pub3-BIB0316|cit316","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939.pub3","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0317|cit317","unstructured":"Gluud C Nikolova D Klingenberg SL Cochrane Hepato-Biliary Group About Cochrane (Cochrane Review Groups (CRGs)) 2016, Issue 5. Art. No.: LIVER"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0318|cit318","unstructured":"GRADEpro Brozek J Oxman A Sch\u00fcnemann H Grade Working Group 2004-2007 2008"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0319|cit319","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0320|cit320","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0321|cit321","volume-title":"International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group","year":"1997"},{"issue":"1","key":"10.1002\/14651858.CD008716.pub3-BIB0322|cit322","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-1746.2008.05582.x","article-title":"l ornithine l aspartate in the management of hepatic encephalopathy: a meta analysis","volume":"24","author":"Jiang","year":"2009","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"10.1002\/14651858.CD008716.pub3-BIB0323|cit323","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003047.pub3","article-title":"Dopamine agents for hepatic encephalopathy","author":"Junker","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD008716.pub3-BIB0324|cit324","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0325|cit325","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"12","key":"10.1002\/14651858.CD008716.pub3-BIB0326|cit326","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD008716.pub3-BIB0327|cit327","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1651-2227.2010.01878.x","article-title":"Prolonged faecal excretion following a single dose of probiotic in low birth weight infants","volume":"99","author":"McGee","year":"2010","journal-title":"Acta Paediatrica"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0328|cit328","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0329|cit329","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2014"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0330|cit330","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM199708143370707","article-title":"Treatment of hepatic encephalopathy","volume":"337","author":"Riordan","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0331|cit331","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jn\/130.2.396S","article-title":"The role of probiotic cultures in the control of gastrointestinal health","volume":"130","author":"Rolfe","year":"2000","journal-title":"Journal of Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD008716.pub3-BIB0332|cit332","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0266462303000552","article-title":"Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches","volume":"19","author":"Royle","year":"2003","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0333|cit333","unstructured":"Saab S Suraweera D Au J Saab EG Alper TS Tong MJ Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials Liver International"},{"issue":"35","key":"10.1002\/14651858.CD008716.pub3-BIB0334|cit334","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"issue":"6","key":"10.1002\/14651858.CD008716.pub3-BIB0335|cit335","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0336|cit336","doi-asserted-by":"crossref","first-page":"361S","DOI":"10.1093\/ajcn\/73.2.361s","article-title":"Probiotics, prebiotics, and synbiotics - approaching a definition","volume":"73","author":"Schrezenmeir","year":"2001","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD008716.pub3-BIB0337|cit337","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0338|cit338","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Sharon","year":"2006","journal-title":"Journal of the Medical Library Association"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0339|cit339","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","article-title":"Meta analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy","volume":"33","author":"Shukla","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0340|cit340","doi-asserted-by":"crossref","unstructured":"Stepanova M Mishra A Venkatesan C Younossi ZM In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009 Clinical Gastroenterology and Hepatology 2012 10 9 1034 41.e1","DOI":"10.1016\/j.cgh.2012.05.016"},{"issue":"10","key":"10.1002\/14651858.CD008716.pub3-BIB0341|cit341","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1155\/2013\/547670","article-title":"Minimal hepatic encephalopathy","volume":"27","author":"Stinton","year":"2013","journal-title":"Canadian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0342|cit342","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0343|cit343","unstructured":"TSA - Trial Sequential Analysis Copenhagen Trial Unit 2011"},{"issue":"7164","key":"10.1002\/14651858.CD008716.pub3-BIB0344|cit344","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0345|cit345","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2003-42644","article-title":"Pathogenesis of hepatic encephalopathy in acute liver failure","volume":"23","author":"Vaquero","year":"2003","journal-title":"Seminars in Liver Disease"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0346|cit346","volume-title":"SF-36\u00ae Physical and Mental Health Summary Scales: A User's Manual","author":"Ware","year":"1994"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0347|cit347","doi-asserted-by":"crossref","unstructured":"Wetterslev J Thorlund K Brok J Gluud C Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis Journal of Clinical Epidemiology 2008 61 1 64 75","DOI":"10.1016\/j.jclinepi.2007.03.013"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0348|cit348","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD008716.pub3-BIB0349|cit349","doi-asserted-by":"crossref","unstructured":"Zhao LN Yu T Lan SY Hou JT Zhang ZZ Wang SS Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis Clinics and Research in Hepatology and Gastroenterology 2015 39 6 674 82","DOI":"10.1016\/j.clinre.2015.03.008"},{"issue":"11","key":"10.1002\/14651858.CD008716.pub3-BIB0350|cit350","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008716.pub2","article-title":"Probiotics for patients with hepatic encephalopathy","author":"McGee","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD008716.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T11:34:46Z","timestamp":1773747286000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008716.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Hepato-Biliary Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":350,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008716.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727337504.793535959","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}